clinical trial · NCT07737600
A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer
Lepu Biopharma Co., Ltd.·phase2·not yet recruiting·n = 316
Advanced Colorectal CancerMRG0075-Fluorouracil/Leucovorin CalciumBevacizumabOxaliplatinPD-1/VEGF antibodyCapecitabine
brief summary
This is a Phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of MRG007 combination therapy in patients with advanced colorectal cancer.
started
Aug 1, 2026
primary completion
Dec 1, 2028
completion
Dec 1, 2029
last updated
Jul 30, 2026
official title
Phase Ib/II Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Efficacy of MRG007 Combination Therapy in Patients With Advanced Colorectal Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol